Novel HDAC inhibitor MAKV-8 and imatinib synergistically kill chronic myeloid leukemia cells via inhibition of BCR-ABL/MYC-signaling: effect on imatinib resistance and stem cells

Overview of attention for article published in Clinical Epigenetics, May 2020

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 20 Dimensions

Readers on

mendeley: 33 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 4,778 followers.

RT @Hema_News: Scientists suggest that combinations of histone deacetylase inhibitor-imatinib are likely to overcome drug resistance in #Ch…

21 May 2020

Reply Repost Favourite

Some 5 years ago we developed HDAC inhibitors in Belgium, research groups in Luxembourg and south Korea got interested in them and took the research way ahead and published some results last week. https://t.co/DGFXxJVBVy

21 May 2020

Reply Repost Favourite

Scientists suggest that combinations of histone deacetylase inhibitor-imatinib are likely to overcome drug resistance in #ChronicMyeloidLeukemia pathology. 🔓 Open access: @OAgenetics https://t.co/RlsbFCloiv https://t.co/HTAgd1uX3q

21 May 2020

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.